reports
Kaufman & Broad: 1 director
A director at Kaufman & Broad sold 77,072 shares at 32.444EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...
OSE Immunotherapeutics reçoit un deuxième avis positif du Comité Indép...
OSE Immunotherapeutics reçoit un deuxième avis positif du Comité Indépendant de Surveillance des Données (IDMC) pour l’essai pivot de Phase 3 ARTEMIA évaluant Tedopi® dans le cancer du poumon non à petites cellules Nantes, le 26 février 2026 – 18h00 CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo : OSE) annonce aujourd’hui que le Comité Indépendant de Surveillance des Données (IDMC) a émis une deuxième recommandation positive concernant l’essai pivot de Phase 3 ARTEMIA en cours, évaluant Tedopi® dans le cancer du poumon non à petites cellules (CPNPC) à un stade avancé. L’IDMC a r...
OSE Immunotherapeutics Receives Second Positive IDMC Recommendation fo...
OSE Immunotherapeutics Receives Second Positive IDMC Recommendation for Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer NANTES, France, February 26, 2026 – 6pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced that the Independent Data Monitoring Committee (IDMC) has issued a second positive recommendation for the ongoing pivotal Phase 3 ARTEMIA trial evaluating Tedopi® in advanced non-small cell lung cancer (NSCLC). The IDMC advised that the study should continue as planned, with no protocol changes. In line with the predefined study ...
Elis: Disclosure of trading in own shares occured from February 16 to ...
Elis: Disclosure of trading in own shares occured from February 16 to February 20, 2026 Disclosure of trading in own shares occurred from February 16 to February 20, 2026 Puteaux, February 24, 2026 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from February 16 to February 20, 2026 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025: Aggregated presentation: Issuer nameIssuer code(LEI) Transaction dateISIN CodeDaily total V...
Elis : Déclaration des transactions sur actions propres du 16 février ...
Elis : Déclaration des transactions sur actions propres du 16 février au 20 février 2026 Déclaration des transactions sur actions propres réalisées du 16 février au 20 février 2026 Puteaux, le 24 février 2026 Conformément à la réglementation relative aux rachats d’actions, notamment le Règlement (UE) 2016/1052, Elis déclare ci-après les achats d’actions propres réalisés du 16 février 2026 au 20 février 2026 dans le cadre du programme de rachat autorisé par la 24ème résolution de l’assemblée générale des actionnaires du 22 mai 2025 : Présentation agrégée : Nom del'émetteurCode Ide...
Elis: Amy Flikerski steps down from the Elis Supervisory Board
Elis: Amy Flikerski steps down from the Elis Supervisory Board Amy Flikerski steps down from the Elis Supervisory Board Puteaux, 19 February 2026 – Amy Flikerski, a member of the Supervisory Board of Elis since June 2020, originally proposed by CPP Investments, has informed Elis that she was resigning from her duties of the Supervisory Board of Elis, effective February 18, 2026. In this role, she also served on the Corporate Social Responsibility Committee. This decision follows the sale of 7,027,199 Elis shares announced on February 12, 2026, and is in accordance with the governance agre...
Elis : Amy Flikerski quitte le Conseil de surveillance d'Elis
Elis : Amy Flikerski quitte le Conseil de surveillance d'Elis Amy Flikerski quitte le Conseil de surveillance d'Elis Puteaux, le 19 février 2026 – Amy Flikerski, membre du Conseil de surveillance d’Elis depuis juin 2020, nommée sur proposition de CPP Investments, a informé Elis qu’elle démissionnait du Conseil de surveillance avec effet au 18 février 2026. Amy Flikerski était également membre du comité responsabilité sociale, environnementale et sociétale. Cette décision fait suite à la cession de 7 027 199 actions Elis, annoncée le 12 février 2026, et s’inscrit dans le cadre de l’accord ...
- Luis de Toledo Heras
VCT VICAT-CIMENTS VICAT SA
DKSH DKSH HOLDING AG
INEA FONCIERE INEA
NOEJ NORMA GROUP SE
ISP INTESA SANPAOLO S.P.A.
BON BONDUELLE SCA
SOLB SOLVAY SA
HEIJM HEIJMANS N.V. CERT
NDA
UCG AURUBIS AG
CON UNICREDIT S.P.A.
ENG CONZZETA AG
ALSN ENAGAS SA
TLV ALSO HOLDING AG
SANT BANCA TRANSILVANIA S.A.
ALFEN S&T AG
ALFEN NV
- Luis de Toledo Heras
DKSH DKSH HOLDING AG
INEA FONCIERE INEA
NOEJ NORMA GROUP SE
ISP INTESA SANPAOLO S.P.A.
BON BONDUELLE SCA
SOLB SOLVAY SA
HEIJM HEIJMANS N.V. CERT
NDA
UCG AURUBIS AG
CON UNICREDIT S.P.A.
ENG CONZZETA AG
ALSN ENAGAS SA
TLV ALSO HOLDING AG
SANT BANCA TRANSILVANIA S.A.
ALFEN S&T AG
ALFEN NV
Elis: Disclosure of trading in own shares occured from February 9 to F...
Elis: Disclosure of trading in own shares occured from February 9 to February 13, 2026 Disclosure of trading in own shares occurred from February 9 to February 13, 2026 Puteaux, February 17, 2026 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from February 9 to February 13, 2026 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025: Aggregated presentation: Issuer nameIssuer code(LEI) Transaction dateISIN CodeDaily total Volu...
Elis : Déclaration des transactions sur actions propres du 9 février a...
Elis : Déclaration des transactions sur actions propres du 9 février au 13 février 2026 Déclaration des transactions sur actions propres réalisées du 9 février au 13 février 2026 Puteaux, le 17 février 2026 Conformément à la réglementation relative aux rachats d’actions, notamment le Règlement (UE) 2016/1052, Elis déclare ci-après les achats d’actions propres réalisés du 9 février 2026 au 13 février 2026 dans le cadre du programme de rachat autorisé par la 24ème résolution de l’assemblée générale des actionnaires du 22 mai 2025 : Présentation agrégée : Nom del'émetteurCode Identi...
- Thijs Berkelder
Elis: 1 director
A director at Elis bought 7,027,199 shares at 25.000EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
- Thymen Rundberg
- Tijs Hollestelle
Alfen/Another transitional year/HOLD
Alfen reported broadly in line 4Q25 results but lowered its FY26 outlook. There is no tangible evidence of a pending volume-driven recovery in the 4Q25 performance of the Smart Grid and the EV Charging division. We increase our FY26 revenue estimate by 0.5% to the mid-point of Alfen's new revenue guidance and cut our FY26F adjusted EBITDA estimate by 6% to €26.1m. This reflects an adjusted EBITDA margin of 5.7%, slightly ahead of the company's mid-point guidance aiming for 5.5%. Management execu...
- Jerôme Bodin
CEC CECONOMY AG
BVI BUREAU VERITAS SA
MF WENDEL SE
SZG SALZGITTER AG
DEC JCDECAUX SA
TYRES NOKIAN RENKAAT OYJ
ASY ASSYSTEM SA
GXI GERRESHEIMER AG
PIG HAULOTTE GROUP SA
VOE VOESTALPINE AG
CIE CIE AUTOMOTIVE S.A.
BRNL BRUNEL INTERNATIONAL N.V.
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
COFA COFACE SA
ECONT ECONOCOM GROUP SE CLASS D
ALFEN ALFEN NV
TUI TUI AG
NCH2 THYSSENKRUPP NUCERA AG & CO.
SCHOTT PHARMA AG
AQ AQUILA PART PROD COM
AMS AMS-OSRAM AG
- Jerôme Bodin
CEC CECONOMY AG
BVI BUREAU VERITAS SA
MF WENDEL SE
SZG SALZGITTER AG
DEC JCDECAUX SA
TYRES NOKIAN RENKAAT OYJ
ASY ASSYSTEM SA
GXI GERRESHEIMER AG
PIG HAULOTTE GROUP SA
VOE VOESTALPINE AG
CIE CIE AUTOMOTIVE S.A.
BRNL BRUNEL INTERNATIONAL N.V.
ROVI LABORATORIOS FARMACEUTICOS ROVI S.A.
COFA COFACE SA
ECONT ECONOCOM GROUP SE CLASS D
ALFEN ALFEN NV
TUI TUI AG
NCH2 THYSSENKRUPP NUCERA AG & CO.
SCHOTT PHARMA AG
AQ AQUILA PART PROD COM
AMS AMS-OSRAM AG
- ING Helpdesk
Benelux Morning Notes
ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...
- Guy Sips
- Mathijs Geerts Danau
- Michiel Declercq
- Thibault Leneeuw
- Thomas Couvreur
- Wim Hoste
Elis: Disclosure of trading in own shares occured from February 2 to F...
Elis: Disclosure of trading in own shares occured from February 2 to February 6, 2026 Disclosure of trading in own shares occurred from February 2 to February 6, 2026 Puteaux, February 10, 2026 In accordance with the regulations on share buybacks, in particular Regulation (EU) 2016/1052, Elis hereby declares the purchases of its own shares made from February 2 to February 6, 2026 under the buyback program authorized by the 24th resolution of the General Shareholders' Meeting of May 22, 2025: Aggregated presentation: Issuer nameIssuer code(LEI) Transaction dateISIN CodeDaily total Volume ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.